Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01213342 · ClinicalTrials.gov registry record · NA
Omega-3 Fatty Acid Supplements and Dry Eye
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01213342 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 35 participants.
The verdict
NCT01213342, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Omega-3 fatty acids have been associated with a decline in inflammation. As dry eye disease is associated with inflammation of the ocular surface (DEWS report, Ocular Surface, 2007), the investigators hypothesize that the omega-3 fatty acid supplements used in this study will help to improve dry eye signs, such as eye surface irritation (staining) and tear film osmolarity, which is an overall measure of tear film stability and dry eye status. Further, the investigators hypothesize that dry eye symptoms, the end result of dry eye disease, such as discomfort and burning, will also improve with supplementation.
Interventions
- DIETARY_SUPPLEMENT Omega-3 Fatty Acid
- DIETARY_SUPPLEMENT Soybean Soft Gels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01213342
The ClinicalTrials.gov registry entry for NCT01213342 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omega-3 Fatty Acid is the first listed.
NCT01213342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01213342 about?
NCT01213342 is a clinical study titled "Omega-3 Fatty Acid Supplements and Dry Eye". Omega-3 fatty acids have been associated with a decline in inflammation. As dry eye disease is associated with inflammation of the ocular surface (DEWS report, Ocular Surface, 2007), the investigators hypothesize that the omega-3 fatty acid supplements used in this study will help to improve dry eye...
What is the current status of trial NCT01213342?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2010-05. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01213342?
The interventions under investigation include: Omega-3 Fatty Acid (DIETARY_SUPPLEMENT), Soybean Soft Gels (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01213342?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.